CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,016,000 | +4.3% | 806,465 | +23.4% | 0.15% | +12.6% |
| Q3 2018 | $19,198,000 | -47.4% | 653,658 | -18.5% | 0.14% | -50.4% |
| Q2 2018 | $36,470,000 | +25.5% | 802,068 | +45.7% | 0.27% | +21.4% |
| Q1 2018 | $29,057,000 | -15.5% | 550,315 | +8.9% | 0.22% | -14.8% |
| Q4 2017 | $34,378,000 | -9.2% | 505,555 | +10.0% | 0.26% | -9.6% |
| Q3 2017 | $37,860,000 | +28.3% | 459,470 | +45.8% | 0.29% | +15.5% |
| Q2 2017 | $29,509,000 | +23.4% | 315,170 | -16.1% | 0.25% | +22.9% |
| Q1 2017 | $23,910,000 | +25.4% | 375,530 | -12.5% | 0.20% | +22.8% |
| Q4 2016 | $19,064,000 | +185.6% | 429,185 | +23.4% | 0.17% | +227.5% |
| Q1 2016 | $6,675,000 | – | 347,660 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |